Today, November 4, 2021, Mr. Xu Bo, Dept of Cardiology, Fuwai hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China, presented the results of the FAVOR III China Outcome trial entitled “A sham-controlled Randomized Trial Comparing QFR-guided and angiography-guided PCI” as a Late-Breaking Clinical Trial (LBCT) at the TCT2021 congress.